School of Medicine


Showing 771-780 of 2,398 Results

  • Sejal Tyle Hathi, MD MBA

    Sejal Tyle Hathi, MD MBA

    Clinical Assistant Professor, Medicine

    BioDr. Sejal Tyle Hathi is a board-certified physician and nationally recognized public health leader with more than 15 years of experience advancing physical and mental health, women's rights, and public policy in the United States and globally.

    She serves as the 4th permanent Director of the Oregon Health Authority, appointed by Governor Tina Kotek and unanimously confirmed by the Oregon Senate to oversee all health care and public health services, policies, and programs for the State of Oregon. Most recently, she served as New Jersey's deputy health commissioner and state health officer — a position she held after two years as the Biden White House's Senior Policy Advisor for Public Health, where she led several presidential priorities across mental health, climate and health, public health preparedness, and supply chain policy. She has also held joint faculty appointments as an assistant professor of medicine at the Johns Hopkins School of Medicine & Bloomberg School of Public Health.

    Dr. Hathi grew up in Fremont, California and received her B.S. with honors from Yale University and her M.D. / M.B.A. from Stanford University, where she studied as a Harry S. Truman Scholar and Paul & Daisy Soros Fellow. She completed her clinical training in internal medicine and primary care at Harvard Medical School and the Massachusetts General Hospital.

  • Zihuai He

    Zihuai He

    Associate Professor (Research) of Neurology and Neurological Sciences (Neurology Research), of Medicine (BMIR) and, by courtesy, of Biomedical Data Science

    Current Research and Scholarly InterestsStatistical genetics and other omics to study Alzheimer's disease and aging.

  • Rose Heald

    Rose Heald

    Masters Student in Translational Research and Applied Medicine, admitted Autumn 2025

    BioAs a Master’s student in Translational Research and Applied Medicine at Stanford Medicine, I’m passionate about bridging the gap between scientific discovery and real-world clinical impact. My career interests lie at the intersection of science and business, with a focus on advancing the development and implementation of novel therapeutics—particularly in the areas of genetics, rare disease, and neurodegenerative diseases.

    I bring experience in clinical research, including work on the BabySeq Project, a pioneering study of genomic newborn screening (gNBS). This experience sparked my ongoing interest in how genomic technologies can be implemented to identify actionable health risks early in life. I continue to contribute to this field through my involvement with the International Consortium on Newborn Sequencing (ICoNS), a global initiative advancing gNBS research.

  • Gregory M. Heestand, MD

    Gregory M. Heestand, MD

    Clinical Associate Professor, Medicine - Oncology

    BioDr. Heestand is a board-certified medical oncologist with a focus on gastrointestinal cancers, primarily hepatocellular carcinoma, cholangiocarcinoma, and gallbladder cancer. He serves as the medical oncology champion of the Stanford Hepatobiliary Tumor Board, as well as the principal investigator of multiple clinical trials. He collaborates with campus laboratories to help develop new biomarker and treatment technologies. He is the former director of the Stanford Oncology Fellowship Program.

    Dr. Heestand and his team take great pride in helping patients and their families face gastrointestinal cancer.

    Outside of the clinic, Dr. Heestand enjoys playing the piano, teaching his kids about music, cooking for friends and family, and surfing the internet for interesting things to read.

  • Shireen N. Heidari

    Shireen N. Heidari

    Clinical Associate Professor, Medicine - Primary Care and Population Health

    BioShireen Heidari, MD is a palliative care and family medicine physician. She works as part of the inpatient palliative care consult team providing symptom management and support for patients and families facing any stage of a serious illness. Dr. Heidari is the program director for the Stanford University Hospice and Palliative Fellowship. She previously served as the clinical lead for the Stanford site of the PERIOP-PC Study, collaborating with the surgical department to evaluate the impact of early palliative care support for patients and family members preparing for major upper gastrointestinal cancer surgery.

    Dr. Heidari is also a writer whose pieces about the importance of human connection, tough conversations, and stigma around healthcare workers seeking help for their mental health have been published in The New England Journal of Medicine, The Lancet Respiratory Medicine, CHEST, The Journal of Pain and Symptom Management, and the Intima. She hopes that by sharing her own story, she can continue being part of these conversations as we advocate for culture change in medicine and more sustainable practice.

    Before moving to northern California, Dr. Heidari attended medical school at Boston University, completed her residency at UC San Diego where she served as chief resident, followed by palliative fellowship at UCLA. Outside of her clinical and mentorship work, she is likely writing creatively or outside with her husband chasing their dogs. She is currently writing her first fiction novel.